Science review: Cell membrane expression (connectivity) regulates neutrophil delivery, function and clearance

Critical Care

Volumn 7, Issue 4, 2003, Pages 291-307

  Seely, Andrew J E ^a   Pascual, José L ^b   Christou, Nicolas V ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Apoptosis; Chemotaxis; Connectivity; Delivery; Neutrophil; Receptors

Indexed keywords

CD11B ANTIGEN; CD18 ANTIGEN; CD31 ANTIGEN; CELL ADHESION MOLECULE; CHEMOATTRACTANT; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS ANTIGEN; FAS LIGAND; GLYCOPROTEIN P 15095; IMMUNOGLOBULIN; INTERCELLULAR ADHESION MOLECULE 3; L SELECTIN; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MEMBRANE PROTEIN; PADGEM PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR 1;

ANTIMICROBIAL ACTIVITY; APOPTOSIS; CELL DEATH; CELL FUNCTION; CELL INTERACTION; HOST RESISTANCE; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MEMBRANE; LIFE CYCLE; MEDICAL RESEARCH; MICROENVIRONMENT; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TISSUE INJURY; TREATMENT OUTCOME;

ANTIGENS, CD; APOPTOSIS; BLOOD BACTERICIDAL ACTIVITY; CANADA; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; HUMANS; NEUTROPHILS; PHAGOCYTOSIS;

EID: 0042196164     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc1853     Document Type: Review

References (175)

1. Baehner RL (editor). Neutrophil structure and function in Hematology: Basic Principles and Practice. New York: Churchill-Livingstone 2000, Chapter 38: page 667-669.
2. Cannistra SA, Griffin JD: Regulation of the production and function of granulocytes and monocytes. Semin Hematol 1988, 25:173-188.
3. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1). N Engl J Med 1992, 327:28-35.
4. Tidow N, Welte K: Advances in understanding postreceptor signaling in response to granulocyte colony-stimulating factor. Curr Opin Hematol 1997, 4:171-175.
5. Khwaja A, Carver J, Jones HM, Linch DC: Dynamic modulation of the cell surface expression of the granulocyte-macrophage colony-stimulating factor receptor. Br J Haematol 1993, 85:42-49.
6. Hermans MH, Antonissen C, Ward AC, Mayen AE, Ploemacher RE, Touw IP: Sustained receptor activation and hyperproliferation in response to granulocyte colony-stimulating factor (G-CSF) in mice with a severe congenital neutropenia/acute myeloid leukemia-derived mutation in the G-CSF receptor gene. J Exp Med 1999, 189:683-692.
7. Ward AC, van Aesch YM, Schelen AM, Touw IP: Defective internalization and sustained activation of truncated granulocyte colony-stimulating factor receptor found in severe congenital neutropenia/acute myeloid leukemia. Blood 1999, 93:447-458.
8. Shoup M, Weisenberger JM, Wang JL, Pyle JM, Gamelli RL, Shankar R: Mechanisms of neutropenia involving myeloid maturation arrest in burn sepsis. Ann Surg 1998, 228:112-122.
9. Boggs DR: The kinetics of neutrophilic leukocytes in health and in disease. Semin Hematol 1967, 4:359-386.
10. Hogg JC: Neutrophil kinetics and lung injury. Physiol Rev 1987, 67:1249-1295.
11. Downey GP, Worthen GS, Henson PM Hyde DM: Neutrophil sequestration and migration in localized pulmonary inflammation. Capillary localization and migration across the inter-alveolar septum. Am Rev Respir Dis 1993, 147:168-176.
12. Schmid-Schonbein GW, Usami S, Skalak R, Chien S: The interaction of leukocytes and erythrocytes in capillary and post-capillary vessels. Microvasc Res 1980, 19:45-70.
13. Blixt A, Jonsson P, Braide M, Bagge U: Microscopic studies on the influence of erythrocyte concentration on the post-junctional radial distribution of leukocytes at small venular junctions. Int J Microcirc Clin Exp 1985, 4:141-156.
14. Firrell JC, Lipowsky HH: Leukocyte margination and deformation in mesenteric venules of rat. Am J Physiol 1989, 256: H1667-H1674.
15. Perry MA, Granger DN: Role of CD11/CD18 in shear rate-dependent leukocyte-endothelial cell interactions in cat mesenteric venules. J Clin Invest 1991, 87:1798-1804.
16. Springer TA: Traffic Signals for Lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994, 76: 301-314.
17. Kubes P, Jutila M, Payne D: Therapeutic potential of inhibiting leukocyte rolling in ischemia/reperfusion. J Clin Invest 1995, 95:2510-2519.
18. Ley K, Bullard DC, Arbones ML, Bosse R, Vestweber D, Tedder TF, Beaudet AL: Sequential contribution of L- and P-selectin to leukocyte rolling in vivo. J Exp Med 1995, 181:669-675.
19. Rosen SD: Cell surface lectins in the immune system. Semin Immunol 1993, 5:237-247.
20. Spertini O, Luscinskas FW, Kansas GS, Munro JM, Griffin JD, Gimbrone MA Jr, Tedder TF: Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol 1991, 147:2565-2573.
21. Kanwar S, Bullard DC, Hickey MJ, Smith CW, Beaudet AL, Wolitzky BA, Kubes P: The association between alpha4-integrin, P-selectin, and E-selectin in an allergic model of inflammation. J Exp Med 1997, 185:1077-1087.
22. Mulligan MS, Varani J, Dame MK, Lane CL, Smith CW, Anderson DC, Ward PA: Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats. J Clin Invest 1991, 88:1396-1406.
23. Lindbom L, Xie X, Raud J, Hedqvist P: Chemoattractant-induced firm adhesion of leukocytes to vascular endothelium in vivo is critically dependent on initial leukocyte rolling. Acta Physiol Scand 1992, 146:415-421.
24. Von Andrian UH, Hansell P, Chambers JD, Berger EM, Torres Filho I, Butcher EC, Arfors KE: L-selectin function is required for beta 2-integrin-mediated neutrophil adhesion at physiological shear rates in vivo. Am J Physiol 1992, 263:H1034-H1044.
25. Bienvenu K, Granger DN: Molecular determinants of shear rate-dependent leukocyte adhesion in postcapillary venules. Am J Physiol 1993, 264:H1504-H1508.
26. Mulligan MS, Miyasaka M, Tamatani T, Jones ML, Ward PA: Requirements for L-selectin in neutrophil-mediated lung injury in rats. J Immunol 1994, 152:832-840.
27. Ferri LE, Pascual J, Seely AJ, Chaudhury P, Christou NV: Soluble L-selectin attenuates tumor necrosis factor-alpha-mediated leukocyte adherence and vascular permeability: a protective role for elevated soluble L-selectin in sepsis. Crit Care Med 2002, 30:1842-7.
28. Anderson DC, Springer TA: Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150,95 glycoproteins. Annu Rev Med 1987, 38:175-194.
29. Smith CW, Rothlein R, Hughes BJ, Mariscalco MM, Rudloff HE, Schmalstieg FC, Anderson DC: Recognition of an endothelial determinant for CD 18-dependent human neutrophil adherence and transendothelial migration. J Clin Invest 1988, 82:1746-1756.
30. Granger DN, Kubes P: The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukocyte Biol 1994, 55:662-675.
31. Zimmerman GA, Prescott SM, McIntyre TM: Endothelial cell interactions with granulocytes: tethering and signaling molecules. Immunol Today 1992, 13:93-100.
32. von Andrian UH, Chambers JD, McEvoy LM, Bargatze RF, Arfors KE, Butcher EC: Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc Natl Acad Sci USA 1991, 88:7538-7542.
33. Argenbright LW, Letts LG, Rothlein R: Monoclonal antibodies to the leukocyte membrane CD18 glycoprotein complex and to intercellular adhesion molecule-1 inhibit leukocyte-endothelial adhesion in rabbits. J Leukoc Biol 1991, 49:253-257.
34. Smith CW: Endothelial adhesion molecules and their role in inflammation. Can J Physiol Pharmacol 1993, 71:76-87.
35. Doerschuk CM, Winn RK, Coxson HO, Harlan JM: CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J Immunol 1990, 144:2327-2333.
36. Winn RK, Harlan JM: CD18-independent neutrophil and mononuclear leukocyte emigration into the peritoneum of rabbits. J Clin Invest 1993, 92:1168-1173.
37. Thomas DD, Sharar SR, Winn RK, Chi EY, Verrier ED, Allen MD, Bishop MJ: CD18-independent mechanism of neutrophil emigration in the rabbit lung after ischemia-reperfusion. Ann Thorac Surg 1995, 60:1360-1366.
38. Langdale LA, Flaherty LC, Liggitt HD, Harlan JM, Rice CL, Winn RK: Neutrophils contribute to hepatic ischemia-reperfusion injury by a CD18- independent mechanism. J Leukoc Biol 1993, 53:511-517.
39. Conlan JW, North RJ: Listeria monocytogenes, but not Salmonella typhimurium, elicits a CD18-independent mechanism of neutrophil extravasation into the murine peritoneal cavity. Infect Immun 1994, 62:2702-2706.
40. Kubes P, Niu XF, Smith CW, Kehrli ME Jr, Reinhardt PH, Woodman RC: A novel beta 1-dependent adhesion pathway on neutrophils: a mechanism invoked by dihydrocytochalasin B or endothelial transmigration. FASEB J 1995, 9: 1103-1111.
41. Krauss K, Altevogt P: Integrin leukocyte function-associated antigen-1-mediated cell binding can be activated by clustering of membrane rafts. J Biol Chem 1999, 274:36921-36927.
42. Hermanowski-Vosatka A, Van Strijp JA, Swiggard WJ, Wright SD: Integrin modulating factor-1: a lipid that alters the function of leukocyte integrins. Cell 1992, 68:341-352.
43. Carlos TM, Harlan JM: Membrane proteins involved in phagocyte adherence to endothelium. Immunol Rev 1990, 114:5-28.
44. Carveth HJ, Bohnsack JF, McIntyre TM, Baggiolini M, Prescott SM, Zimmerman GA: Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins. Biochem Biophys Res Commun 1989, 162:387-393.
45. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA: Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med 1990, 171: 1155-1162.
46. Pober JS, Cotran RS: The role of endothelial cells in inflammation. Transplantation 1990, 50:537-544.
47. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 1990, 70:427-451.
48. Yan HC, Juhasz I, Pilewski J, Murphy GF, Herlyn M, Albelda SM: Human/severe combined immunodeficient mouse chimeras. An experimental in vivo model system to study the regulation of human endothelial cell-leukocyte adhesion molecules. J Clin Invest 1993, 91:986-996.
49. Smith CW: Leukocyte-endothelial cell interactions. Semin Hematol 1993, 30:45-53; discussion 54-55.
50. Del Maschio A, Zanetti A, Corada M, Rival Y, Ruco L, Lampugnani MG, Dejana E: Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol 1996, 135:497-510.
51. Burns AR, Walker DC, Brown ES, Thurmon LT, Bowden RA, Keese CR, Simon SI, Entman ML, Smith CW: Neutrophil transendothelial migration is independent of tight junctions and occurs preferentially at tricellular corners. J Immunol 1997, 159:2893-2903.
52. Kurose I, Anderson DC, Miyasaka M, Tamatani T, Paulson JC, Todd RF, Rusche JR, Granger DN: Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res 1994, 74:336-343.
53. Zimmerman BJ, Holt JW, Paulson JC, Anderson DC, Miyasaka M, Tamatani T, Todd RF III, Rusche JR, Granger DN: Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. Am J Physiol 1994, 266:H847-H853.
54. Berman ME, Muller WA: Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM- 1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J Immunol 1995, 154:299-307.
55. Kuwabara H, Tanaka S, Sakamoto H, Oryu M, Uda H: Antibody mediated ligation of platelet/endothelial cell adhesion molecule-1 (PECAM-1) on neutrophils enhances adhesion to cultured human dermal microvascular endothelial cells. Kobe J Med Sci 1996, 42:233-241.
56. Muller WA, Weigl SA, Deng X, Phillips DM: PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993, 178:449-460.
57. Christofidou-Solomidou M, Nakada MT, Williams J, Muller WA, DeLisser HM: Neutrophil platelet endothelial cell adhesion molecule-1 participates in neutrophil recruitment at inflammatory sites and is down-regulated after leukocyte extravasation. J Immunol 1997, 158:4872-4878.
58. Ryan GB, Hurley JV: The chemotaxis of polymorphonuclear leucocytes towards damaged tissue. Br J Exp Pathol 1966, 47: 530-536.
59. Cassatella MA, Bazzoni F, Ceska M, Ferro I, Baggiolini M, Berton G: IL-8 production by human polymorphonuclear leukocytes. The chemoattractant formyl-methionyl-leucyl-phenylalanine induces the gene expression and release of IL-8 through a pertussis toxin-sensitive pathway. J Immunol 1992, 148:3216-3220.
60. Kunkel SL, Lukacs NW, Strieter RM: The role of interleukin-8 in the infectious process. Ann N Y Acad Sci 1994, 730:134-143.
61. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980, 286:264-265.
62. Schiffmann E, Corcoran BA, Wahl SM: N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci USA 1975, 72:1059-1062.
63. Fernandez HN, Henson PM, Otani A, Hugh TE: Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol 1978, 120:109-115.
64. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 1991, 9:617-648.
65. Kunkel SL, Lukacs N, Strieter RM: Expression and biology of neutrophil and endothelial cell-derived chemokines. Semin Cell Biol 1995, 6:327-336.
66. Huber AR, Kunkel SL, Todd RFD, Weiss SJ: Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991, 254:99-102. (published errata appear in Science 1991, 254:631 and 1435.)
67. Smart SJ, Casale TB: TNF-alpha-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 1994, 266: L238-L245.
68. Smart SJ, Casale TB: Pulmonary epithelial cells facilitate TNF-alpha-induced neutrophil chemotaxis. A role for cytokine networking. J Immunol 1994, 152:4087-4094.
69. Mulligan MS, Jones ML, Bolanowski MA, Baganoff MP, Deppeler CL, Meyers DM, Ryan US, Ward PA: Inhibition of lung inflammatory reactions in rats by an anti-human IL-8 antibody. J Immunol 1993, 150:5585-5595.
70. Strieter RM, Koch AE, Antony VB, Fick RB Jr, Standiford TJ, Kunkel SL: The immunopathology of chemotactic cytokines: the role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med 1994, 123:183-197.
71. Kupper RW, Dewald B, Jakobs KH, Baggiolini M, Gierschik P: G-protein activation by interleukin 8 and related cytokines in human neutrophil plasma membranes. Biochem J 1992, 282: 429-434.
72. Kelvin DJ, Michiel DF, Johnston JA, Lloyd AR, Sprenger H, Oppenheim JJ, Wang JM: Chemokines and serpentines: the molecular biology of chemokine receptors. J Leukoc Biol 1993, 54: 604-612.
73. Ahuja SK, Murphy PM: The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 1996, 271:20545-20550.
74. Hammond ME, Lapointe GR, Feucht PH, Hilt S, Gallegos CA, Gordon CA, Giedlin MA, Mullenbach G, Tekamp-Olson P: IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors. J Immunol 1995, 155:1428-1433.
75. Santamaria Babi LF, Moser B, Perez Soler MT, Moser R, Loetscher P, Villiger B, Blaser K, Hauser C: The interleukin-8 receptor B and CXC chemokines can mediate transendothelial migration of human skin homing T cells. Eur J Immunol 1996, 26:2056-2061.
76. Botha AJ, Moore FA, Moore EE, Fontes B, Banerjee A, Peterson VM: Postinjury neutrophil priming and activation states: therapeutic challenges [editorial]. Shock 1995, 3:157-166.
77. Guthrie LA, McPhail LC, Henson PM, Johnston RB Jr: Priming of neutrophils for enhanced release of oxygen metabolites by bacterial lipopolysaccharide. Evidence for increased activity of the superoxide-producing enzyme. J Exp Med 1984, 160: 1656-1671.
78. - generation. Lab Invest 1988, 58:448-453.
79. Vercellotti GM, Yin HQ, Gustafson KS, Nelson RD, Jacob HS: Platelet-activating factor primes neutrophil responses to agonists: role in promoting neutrophil-mediated endothelial damage. Blood 1988, 71:1100-1107.
80. Wozniak A, Betts WH, McLennan G, Scicchitano R: Activation of human neutrophils by tachykinins: effect on formyl-methionylleucyl-phenylalanine- and platelet-activating factor-stimulated superoxide anion production and antibody-dependent cell-mediated cytotoxicity. Immunology 1993, 78:629-634.
81. Biffl WL, Moore EE, Moore FA, Carl VS, Kim FJ, Franciose RJ: Interleukin-6 potentiates neutrophil priming with platelet-activating factor. Arch Surg 1994, 129:1131-1136.
82. Forehand JR, Pabst MJ, Phillips WA, Johnston RB Jr: Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst. Role of intracellular free calcium. J Clin Invest 1989, 83:74-83.
83. Gay JC, Beckman JK, Brash AR, Oates JA, Lukens JN: Enhancement of chemotactic factor-stimulated neutrophil oxidative metabolism by leukotriene B4. Blood 1984, 64:780-785.
84. Weisbart RH, Golde DW, Gasson JC: Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors. J Immunol 1986, 137:3584-3587.
85. Atkinson YH, Marasco WA, Lopez AF, Vadas MA: Recombinant human tumor necrosis factor-alpha. Regulation of N- formyl-methionylleucylphenylalanine receptor affinity and function on human neutrophils. J Clin Invest 1988, 81:759-765.
86. O'Flaherty JT, Rossi AG, Redman JF, Jacobson DP: Tumor necrosis factor-alpha regulates expression of receptors for formyl-methionyl-leucyl-phenylalanine, leukotriene B4, and platelet-activating factor. Dissociation from priming in human polymorphonuclear neutrophils. J Immunol 1991, 147:3842-3847.
87. Zimmerli W, Reber AM, Dahinden CA: The role of formylpeptide receptors, C5a receptors, and cytosolic-free calcium in neutrophil priming. J Infect Dis 1990, 161:242-249.
88. Tennenberg SD, Fey DE, Lieser MJ: Oxidative priming of neutrophils by interferon-gamma. J Leukoc Biol 1993, 53:301-308.
89. McColl SR, Beauseigle D, Gilbert C, Naccache PH: Priming of the human neutrophil respiratory burst by granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha involves regulation at a post-cell surface receptor level. Enhancement of the effect of agents which directly activate G proteins. J Immunol 1990, 145:3047-3053.
90. Wozniak A, Betts WH, Murphy GA, Rokicinski M: Interleukin-8 primes human neutrophils for enhanced superoxide anion production. Immunology 1993, 79:608-615.
91. Walker BA, Hagenlocker BE, Ward PA: Superoxide responses to formyl-methionyl-leucyl-phenylalanine in primed neutrophils. Role of intracellular and extracellular calcium. J Immunol 1991, 146:3124-3131.
92. Richter J, Andersson T, Olsson I: Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation. J Immunol 1989, 142:3199-3205.
93. Dewald B, Baggiolini M: Activation of NADPH oxidase in human neutrophils. Synergism between fMLP and the neutrophil products PAF and LTB4. Biochem Biophys Res Commun 1985, 128:297-304.
94. Robinson JM, Badwey JA, Karnovsky ML, Karnovsky MJ: Superoxide release by neutrophils: synergistic effects of a phorbol ester and a calcium ionophore. Biochem Biophys Res Commun 1984, 122:734-739.
95. Partrick DA, Moore FA, Moore EE, Barnett CC Jr, Silliman CC: Neutrophil priming and activation in the pathogenesis of postinjury multiple organ failure. New Horizons 1996, 4:194-210.
96. Moore EE, Moore FA, Franciose RJ, Kim FJ, Biffl WL, Banerjee A: The postischemic gut serves as a priming bed for circulating neutrophils that provoke multiple organ failure. J Trauma 1994, 37:881-887.
97. Tanaka H, Ogura H, Yokota J, Sugimoto H, Yoshioka T, Sugimoto T: Acceleration of superoxide production from leukocytes in trauma patients. Ann Surg 1991, 214:187-192.
98. Smith JA: Neutrophils, host defense, and inflammation: a double-edged sword. J Leukoc Biol 1994, 56:672-686.
99. Haslett C: Introduction: the paradox of inflammation. Semin Cell Biol 1995, 6:315-316.
100. Malech HL, Gallin JI: Current concepts: immunology. Neutrophils in human diseases. N Engl J Med 1987, 317:687-694.
101. Weiss SJ: Tissue destruction by neutrophils. N Engl J Med 1989, 320:365-376.
102. Heijnen IA, van de Winkel JG: Human IgG Fc receptors. Int Rev Immunol 1997, 16:29-55.
103. Chuang FY, Sassaroli M, Unkeless JC: Convergence of Fc gamma receptor IIA and Fc gamma receptor IIIB signaling pathways in human neutrophils. J Immunol 2000, 164:350-360.
104. Repp R, Valerius T, Sendler A, Gramatzki M, Iro H, Kalden JR, Platzer E: Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony- stimulating factor. Blood 1991, 78:885-889.
105. Fjaertoft G, Hakansson L, Ewald U, Foucard T, Venge P: Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res 1999, 45:871-876.
106. Fischer G, Schneider EM, L Moldawer LL, Karcher C, Barth E, Suger-Wiedeck H, Georgieff M, Weiss M: CD64 surface expression on neutrophils is transiently upregulated in patients with septic shock. Intensive Care Med 2001, 27:1848-1852.
107. Hampton MB, Kettle AJ, Winterbourn CC: Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998, 92:3007-3017.
108. Borregaard N, Lollike K, Kjeldsen L, Sengelov H, Bastholm L, Nielsen MH, Bainton DF: Human neutrophil granules and secretory vesicles. Eur J Haematol 1993, 51:187-198.
109. Vaissiere C, Le Cabec V, Maridonneau-Parini I: NADPH oxidase is functionally assembled in specific granules during activation of human neutrophils. J Leukoc Biol 1999, 65:629-634.
110. Varani J, Ward PA: Mechanisms of neutrophil-dependent and neutrophil-independent endothelial cell injury. Biol Signals 1994, 3:1-14.
111. Travis J, Salvesen GS: Human plasma proteinase inhibitors. Annu Rev Biochem 1983, 52:655-709.
112. Vaux DL, Haecker G, Strasser A: An evolutionary perspective on apoptosis. Cell 1994, 76:777-779.
113. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995, 267:1456-1462.
114. Kerr JF, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
115. Majno G, Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995, 146:3-15.
116. Fadok VA, Savill JS, Haslett C, Bratton DL, Doherty DE, Campbell PA, Henson PM: Different populations of macrophages use either the vitronectin receptor or the phosphatidylserine receptor to recognize and remove apoptotic cells. J Immunol 1992, 149:4029-4035.
117. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR: Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995, 182:1545-1556.
118. Fadok VA, Voelker DR, Campbell PA, Bratton DL, Cohen JJ, Noble PW, Riches DW, Henson PM: The ability to recognize phosphatidylserine on apoptotic cells is an inducible function in murine bone marrow-derived macrophages. Chest 1993, 103 (suppl):102S.
119. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH: Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 1994, 84:1415-1420.
120. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C: A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995, 184: 39-51.
121. Ashkenazi A, Dixit VM: Death receptors: signaling and modulation. Science 1998, 281:1305-1308.
122. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV: A novel domain within the 55 kd TNF receptor signals cell death. Cell 1993, 74:845-853.
123. Nagata S: Apoptosis by death factor. Cell 1997, 88:355-365.
124. Smith CA, Farrah T, Goodwin RG: The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell 1994, 76:959-962.
125. Nagata S: Fas and Fas ligand: a death factor and its receptor. Adv Immunol 1994, 57:129-144.
126. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunology Today 1995, 16:569-574.
127. Nagata S, Golstein P: The Fas death factor. Science 1995, 267: 1449-1456.
128. Dhein J, Walczak H, Baumler C, Debatin KM, Krammer PH: Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995, 373:438-441.
129. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995, 181:71-77.
130. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA: Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995, 270:1189-1192.
131. Iwai K, Miyawaki T, Takizawa T, Konno A, Ohta K, Yachie A, Seki H, Taniguchi N: Differential expression of bcl-2 and susceptibility to anti-Fas-mediated cell death in peripheral blood lymphocytes, monocytes, and neutrophils. Blood 1994, 84:1201-1208.
132. Thornberry NA, Lazebnik Y: Caspases: enemies within. Science 1998, 281:1312-1316.
133. Takeda Y, Watanabe H, Yonehara S, Yamashita T, Saito S, Sendo F: Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha. Int Immunol 1993, 5:691-694.
134. Watson RW, Redmond HP, Wang JH, Bouchier-Hayes D: Bacterial ingestion, tumor necrosis factor-alpha, and heat induce programmed cell death in activated neutrophils. Shock 1996, 5:47-51.
135. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 1995, 81:495-504.
136. Baeuerle PA, Henkel T: Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994, 12:141-179.
137. Baldwin AS Jr: The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683.
138. Schutze S, Wiegmann K, Machleidt T, Kronke M: TNF-induced activation of NF-kappa B. Immunobiology 1995, 193:193-203.
139. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 1996, 274:787-789.
140. Wang CY, Mayo MW, Baldwin AS Jr: TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-kappaB. Science 1996, 274:784-787.
141. Van Antwerp DJ, Martin SJ, Verma IM, Green DR: Inhibition of TNF-induced apoptosis by NF-kappa B. Trends Cell Biol 1998, 8:107-111.
142. Homburg CH, Roos D: Apoptosis of neutrophils. Curr Opin Hematol 1996, 3:94-99.
143. Pericle F, Liu JH, Diaz JI, Blanchard DK, Wei S, Forni G, Djeu JY: Interleukin-2 prevention of apoptosis in human neutrophils. Eur J Immunol 1994, 24:440-444.
144. Biffl WL, Moore EE, Moore FA, Barnett CC Jr, Carl VS, Peterson VN: Interleukin-6 delays neutrophil apoptosis. Arch Surg 1996, 131:24-29; discussion 29-30.
145. Kettritz R, Gaido ML, Haller H, Luft FC, Jennette CJ, Falk RJ: Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int 1998, 53:84-91.
146. Adachi S, Kubota M, Lin YW, Okuda A, Matsubara K, Wakazono Y, Hirota H, Kuwakado K, Akiyama Y: In vivo administration of granulocyte colony-stimulating factor promotes neutrophil survival in vitro. Eur J Haematol 1994, 53:129-134.
147. Cox G, Gauldie J, Jordana M: Bronchial epithelial cell-derived cytokines (G-CSF and GM-CSF) promote the survival of peripheral blood neutrophils in vitro. Am J Respir Cell Mol Biol 1992, 7:507-513.
148. Lee A, Whyte MK, Haslett C: Inhibition of apoptosis and prolongation of neutrophil functional longevity by inflammatory mediators. J Leukocyte Biol 1993, 54:283-288.
149. Leuenroth S, Lee C, Grutkoski P, Keeping H, Simms HH: Interleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions. Surgery 1998, 124:409-417.
150. Liles WC, Kiener PA, Ledbetter JA, Aruffo A, Klebanoff SJ: Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J Exp Med 1996, 184:429-440.
151. Tortorella C, Piazzolla G, Spaccavento F, Pece S, Jirillo E, Antonaci S: Spontaneous and Fas-induced apoptotic cell death in aged neutrophils. J Clin Immunol 1998, 18:321-329.
152. Watson RW, O'Neill A, Brannigen AE, Coffey R, Marshall JC, Brady HR, Fitzpatrick JM: Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent. FEBS Lett 1999, 453:67-71.
153. Gamberale R, Giordano M, Trevani AS, Andonegui G, Geffner JR: Modulation of human neutrophil apoptosis by immune complexes. J Immunol 1998, 161:3666-3674.
154. Kasahara Y, Iwai K, Yachie A, Ohta K, Konno A, Seki H, Miyawaki T, Taniguchi N: Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 1997, 89:1748-1753.
155. Aoshiba K, Nakajima Y, Yasui S, Tamaoki J, Nagai A: Red blood cells inhibit apoptosis of human neutrophils. Blood 1999, 93: 4006-4010.
156. Watson RW, Rotstein OD, Nathens AB, Parodo J, Marshall JC: Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement. J Immunol 1997, 158:945-953.
157. Yee J, Giannias B, Kapadia B, Chartrand L, Christou NV: Exudative neutrophils. Modulation of microbicidal function in the inflammatory microenvironment. Arch Surg 1994, 129:99-105.
158. Coble BI, Briheim G, Dahlgren C, Molin L: Function of exudate neutrophils from skin in psoriasis. Int Arch Allergy Appl Immunol 1988, 85:398-403.
159. Wandall JH: Function of polymorphonuclear neutrophilic leucocytes. Comparison of leucocytes from blood and exudate in healthy volunteers. Acta Pathol Microbiol Immunol Scand [C] 1982, 90:7-13.
160. Zimmerli W, Seligmann BE, Gallin JI: Neutrophils are hyperpolarized after exudation and show an increased depolarization response to formyl-peptide but not to phorbol myristate acetate. Eur J Clin Invest 1987, 17:435-441.
161. Zimmerli W, Seligmann B, Gallin JI: Exudation primes human and guinea pig neutrophils for subsequent responsiveness to the chemotactic peptide N-formylmethionylleucylphenylalanine and increases complement component C3bi receptor expression. J Clin Invest 1986, 77:925-933.
162. Ahmed NA, Christou NV: Decreased neutrophil L-selectin expression in patients with systemic inflammatory response syndrome. Clin Invest Med 1996, 19:427-434.
163. Kuhns DB, Long Priel DA, Gallin JI: Loss of L-selectin (CD62L) on human neutrophils following exudation in vivo. Cell Immunol 1995, 164:306-310.
164. Muller WA: The use of anti-PECAM reagents in the control of inflammation. Agents Actions Suppl 1995, 46:147-157.
165. Sengelov H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N: Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol 1995, 154:4157-4165.
166. Biggar WD, Barker C, Hamilton G, Crawford L, Bohn D, Kent G: Migration in vitro by blood and exudate neutrophils assessed serially during an inflammatory response. Immunol Invest 1986, 15:431-438.
167. Mrowietz U, Schroder JM, Brasch J, Christophers E: Infiltrating neutrophils differ from circulating neutrophils when stimulated with C5a, NAP-1/IL-8, LTB4 and FMLP. Scand J Immunol 1992, 35:71-78.
168. Soejima K, Fujishima S, Nakamura H, Waki Y, Nakamura M, Matsubara H, Tasaka S, Sayama K, Ishizaka A, Kanazawa M: Down-modulation of IL-8 receptors, type A and type B, on human lung neutrophils in vivo. Am J Physiol 1997, 273:L618-L625.
169. Seely AJE, Naud JF, Campisi G, Giannias B, Liu S, DiCarlo A, Ferri LE, Pascual JL, Tchervenkov J, Christou NV: Alteration of chemoattractant receptor expression regulates neutrophil chemotaxis in vivo. Ann Surg 2002, 235:550-559.
170. Dransfield I, Buckle AM, Savill JS, McDowall A, Haslett C, Hogg N: Neutrophil apoptosis is associated with a reduction in CD16 (Fc gamma RIII) expression. J Immunol 1994, 153:1254-1263.
171. Homburg CH, de Haas M, von dem Borne AE, Verhoeven AJ, Reutelingsperger CP, Roos D: Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood 1995, 85:532-540.
172. Watson RW, Rotstein OD, Parodo J, Jimenez M, Soric I, Bitan R, Marshall JC. Impaired apoptotic death signaling in inflammatory lung
173. Seely AJ, Swartz DE, Giannias B, Christou NV: Reduction in neutrophil cell surface expression of tumor necrosis factor receptors but not Fas after transmigration: implications for the regulation of neutrophil apoptosis. Arch Surg 1998, 133:1305-1310.
174. Niwa M, Hara A, Kanamori Y, Kohno K, Yoshimi N, Mori H, Uematsu T: Comparison of susceptibility to apoptosis induced by rhTNF-alpha and cycloheximide between human circulating and exudated neutrophils. Life Sci 1997, 61:205-215.
175. Seely AJ, Christou NV: Multiple organ dysfunction syndrome: exploring the paradigm of complex nonlinear systems. Crit Care Med 2000, 28:2193-2200.